Related Experiment Video

Updated: Jul 3, 2026

Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes

Steven K Takemoto1, Wolfgang Arns, Suphamai Bunnapradist

  • 1National Institute of Transplantation, S. Mark Taper Foundation Transplant Center, Los Angeles, CA 90057, USA. sktakemoto@hotmail.com

Transplantation
|July 16, 2008
PubMed

Insights

Randomized controlled trials and outcomes research complement each other in transplantation research. Outcomes research, with minimal bias due to transplant registries, should inform regulatory decisions on efficacy and coverage.

Area of Science:

  • Transplantation research
  • Clinical trial methodology
  • Health outcomes research

Background:

  • Randomized controlled trials (RCTs) and outcomes research offer complementary insights in transplantation.
  • Transplantation procedures present challenges for randomization and blinding in RCTs.
  • Transplant registries minimize sampling bias by including nearly all recipients.

Framework:

  • Examining the suitability of outcomes research to supplement RCTs.
  • Addressing key issues: efficacy vs. effectiveness, internal vs. external validity, data types, limitations, and analysis.
  • Highlighting transplantation as a field pioneering advances in outcomes research.

Implementation:

  • Utilizing comprehensive transplant registries for robust data collection.
  • Adapting methodologies to account for the complexities of transplantation research.
  • Integrating outcomes research findings into the evaluation of interventions.

Implications:

  • Regulatory and reimbursement bodies should incorporate outcomes research into decision-making.
  • Improved assessment of efficacy, effectiveness, and coverage for transplantation interventions.
  • Enhancing the evidence base for clinical practice and policy in transplantation.

More Related Videos

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection05:10

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection

Published on: August 20, 2007

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...